Report Detail
Global Blood Cancer Therapeutics Market Growth (Status and Outlook) 2019-2024
- RnM2837346 |
- 29 January, 2019 |
- Global |
- 118 Pages |
- LPI(LP Information) |
- Other
Blood cancer is an umbrella term for cancers that affect the blood, bone marrow and lymphatic system.
According to this study, over the next five years the Blood Cancer Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Blood Cancer Therapeutics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Blood Cancer Therapeutics market by product type, application, key companies and key regions.
This study considers the Blood Cancer Therapeutics value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Chronic Myeloid Leukemia (CML)
Acute Lymphocytic Leukemia (ALL)
Acute Myeloid Leukemia (AML)
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AbbVie
AstraZeneca
Bristol-Myers Squibb
GlaxoSmithKline
Roche
Novartis
Boehringer Ingelheim
Pfizer
Sanofi
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Blood Cancer Therapeutics market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Blood Cancer Therapeutics market by identifying its various subsegments.
Focuses on the key global Blood Cancer Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Blood Cancer Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Blood Cancer Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Blood Cancer Therapeutics Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Blood Cancer Therapeutics Market Size 2014-2024
- 2.1.2 Blood Cancer Therapeutics Market Size CAGR by Region
- 2.2 Blood Cancer Therapeutics Segment by Type
- 2.2.1 Chronic Myeloid Leukemia (CML)
- 2.2.2 Acute Lymphocytic Leukemia (ALL)
- 2.2.3 Chronic Lymphocytic Leukemia (CLL)
- 2.2.4 Acute Myeloid Leukemia (AML)
- 2.3 Blood Cancer Therapeutics Market Size by Type
- 2.3.1 Global Blood Cancer Therapeutics Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Blood Cancer Therapeutics Market Size Growth Rate by Type (2014-2019)
- 2.4 Blood Cancer Therapeutics Segment by Application
- 2.4.1 Cancer Research Centers
- 2.4.2 Cancer Hospital
- 2.4.3 Surgical Centers
- 2.4.4 Clinics
- 2.5 Blood Cancer Therapeutics Market Size by Application
- 2.5.1 Global Blood Cancer Therapeutics Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Blood Cancer Therapeutics Market Size Growth Rate by Application (2014-2019)
3 Global Blood Cancer Therapeutics by Players
- 3.1 Global Blood Cancer Therapeutics Market Size Market Share by Players
- 3.1.1 Global Blood Cancer Therapeutics Market Size by Players (2017-2019)
- 3.1.2 Global Blood Cancer Therapeutics Market Size Market Share by Players (2017-2019)
- 3.2 Global Blood Cancer Therapeutics Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Blood Cancer Therapeutics by Regions
- 4.1 Blood Cancer Therapeutics Market Size by Regions
- 4.2 Americas Blood Cancer Therapeutics Market Size Growth
- 4.3 APAC Blood Cancer Therapeutics Market Size Growth
- 4.4 Europe Blood Cancer Therapeutics Market Size Growth
- 4.5 Middle East & Africa Blood Cancer Therapeutics Market Size Growth
5 Americas
- 5.1 Americas Blood Cancer Therapeutics Market Size by Countries
- 5.2 Americas Blood Cancer Therapeutics Market Size by Type
- 5.3 Americas Blood Cancer Therapeutics Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Blood Cancer Therapeutics Market Size by Countries
- 6.2 APAC Blood Cancer Therapeutics Market Size by Type
- 6.3 APAC Blood Cancer Therapeutics Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Blood Cancer Therapeutics by Countries
- 7.2 Europe Blood Cancer Therapeutics Market Size by Type
- 7.3 Europe Blood Cancer Therapeutics Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Blood Cancer Therapeutics by Countries
- 8.2 Middle East & Africa Blood Cancer Therapeutics Market Size by Type
- 8.3 Middle East & Africa Blood Cancer Therapeutics Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Blood Cancer Therapeutics Market Forecast
- 10.1 Global Blood Cancer Therapeutics Market Size Forecast (2019-2024)
- 10.2 Global Blood Cancer Therapeutics Forecast by Regions
- 10.2.1 Global Blood Cancer Therapeutics Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Blood Cancer Therapeutics Forecast by Type
- 10.8 Global Blood Cancer Therapeutics Forecast by Application
11 Key Players Analysis
- 11.1 AbbVie
- 11.1.1 Company Details
- 11.1.2 Blood Cancer Therapeutics Product Offered
- 11.1.3 AbbVie Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 AbbVie News
- 11.2 AstraZeneca
- 11.2.1 Company Details
- 11.2.2 Blood Cancer Therapeutics Product Offered
- 11.2.3 AstraZeneca Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 AstraZeneca News
- 11.3 Bristol-Myers Squibb
- 11.3.1 Company Details
- 11.3.2 Blood Cancer Therapeutics Product Offered
- 11.3.3 Bristol-Myers Squibb Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Bristol-Myers Squibb News
- 11.4 GlaxoSmithKline
- 11.4.1 Company Details
- 11.4.2 Blood Cancer Therapeutics Product Offered
- 11.4.3 GlaxoSmithKline Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 GlaxoSmithKline News
- 11.5 Roche
- 11.5.1 Company Details
- 11.5.2 Blood Cancer Therapeutics Product Offered
- 11.5.3 Roche Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Roche News
- 11.6 Novartis
- 11.6.1 Company Details
- 11.6.2 Blood Cancer Therapeutics Product Offered
- 11.6.3 Novartis Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Novartis News
- 11.7 Boehringer Ingelheim
- 11.7.1 Company Details
- 11.7.2 Blood Cancer Therapeutics Product Offered
- 11.7.3 Boehringer Ingelheim Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Boehringer Ingelheim News
- 11.8 Pfizer
- 11.8.1 Company Details
- 11.8.2 Blood Cancer Therapeutics Product Offered
- 11.8.3 Pfizer Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Pfizer News
- 11.9 Sanofi
- 11.9.1 Company Details
- 11.9.2 Blood Cancer Therapeutics Product Offered
- 11.9.3 Sanofi Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Sanofi News
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Blood Cancer Therapeutics . Industry analysis & Market Report on Blood Cancer Therapeutics is a syndicated market report, published as Global Blood Cancer Therapeutics Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Blood Cancer Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
